E11.3521 Type 2 diab w prolif diab rtnop w trctn dtch macula, r eye

Instructional Notes:

E11.3521
Description: Type 2 diab w prolif diab rtnop w trctn dtch macula, r eye
↓
E11.352
Description: Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
↓
E11.35
Description: Type 2 diabetes mellitus with proliferative diabetic retinopathy
↓
E11.3
Description: Type 2 diabetes mellitus with ophthalmic complications
↓
E11
Description: Type 2 diabetes mellitus
Exclude1:
- diabetes mellitus due to underlying condition (E08.-)
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
Use Additional Code:
- code to identify control using:
- injectable non-insulin antidiabetic drugs (Z79.85)
- insulin (Z79.4)
- oral antidiabetic drugs (Z79.84)
- oral hypoglycemic drugs (Z79.84)
Include:
- diabetes (mellitus) due to insulin secretory defect
- diabetes NOS
- insulin resistant diabetes (mellitus)
↓
E08-E13
Description: Diabetes mellitus (E08-E13)
↓
E00-E89
Description: Endocrine, nutritional and metabolic diseases
Exclude1:
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.